Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Guide on the requirements for providing information related to drug shortages (GUI-0146) Download in PDF format (PDF format, 795 KB, 12 pages) Organization: Health Canada Published: 2021-11-28 Date of implementation: 2021-11-08 A public consultation on proposed changes to this…
Guide to distributing drugs intended for the Canadian market for consumption or use outside Canada (GUI-0145) Download in PDF format (PDF format, 790 KB, 14 pages) Organization: Health Canada Published: 2021-11-28 Date of implementation: 2021-11-28 A public consultation on…
Notice: Prescription Drug List (PDL): Multiple Additions Date: November 15, 2021 Our file number: 21-119409-776 The purpose of this Notice of Amendment is to notify about the additions of Dequalinium chloride, Enfortumab vedotin, Somatrogon, and Tralokinumab to the Prescription…
Notice of Intent to Amend the Prescription Drug List (PDL): Brimonidine November 15, 2021 Our file number: 21-119262-176 The purpose of this Notice of Intent to Amend is to notify the revision of brimonidine or its salts on the Prescription Drug List (PDL), by adding a qualifier.…
Guidance on post-notice of compliance (NOC) quality changes to drugs for human use: Consultation closed From Health Canada Current status: Closed This consultation ran from August 6, 2021, to December 15, 2021. Stakeholders were invited to comment on draft guidance documents on…
Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution) December 6, 2021 Our file number: 21-120692-21 The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a…
Scientific Advisory Committee on Health Products for Women (SAC-HPW): Summary of findings and advice, June 23 rd , 2021 virtual meeting Context The Scientific Advisory Committee on Health Products for Women (SAC-HPW)'s mandate is to provide Health Canada with timely…
Notice of Consultation on the Prescription Drug List (PDL): Betaine December 22, 2021 Our file number: 21-121823-438 This Notice of Consultation provides an opportunity to comment on the proposal to remove "Betaine or its salts" from the Veterinary part of the Prescription Drug…
Joint notice on collaboration between the Competition Bureau and Health Products and Food Branch of Health Canada January 10, 2022 Our file number: 21-120410-226 The Competition Bureau (the Bureau) and Health Canada's Health Products and Food Branch (HPFB) recognize the benefits…
Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone) January 18, 2022 Our file number: 22-100544-803 The purpose of this Notice of Intent to Amend is to announce that metamizole (also known as ‘dipyrone’) will be added to the Prescription Drug List (PDL).…
Page 4278 sur 6399Affichage de 42771 à 42780 sur 63986
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
